Swartz Allison sold $15K of PGNY
Swartz Allison (EVP, GC) sold 599 shares of Progyny, Inc. (PGNY) at $25.08 on 2026-06-04 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure may slightly affect sentiment/positioning but does not change the company’s fundamentals or near-term outlook based on the provided facts.
Market read
A routine 10b5-1 insider sale for PGNY; treat as low-signal unless additional filings show a pattern.
What to watch
The sale size ($15,022.92) is small relative to typical liquidity, and 10b5-1 plans reduce interpretability of intent.
Background
SEC Form 4 reports insider transactions; this one is an open-market sale by an EVP/GC executed under a pre-arranged 10b5-1 plan.
Ticker impact
Progyny disclosed an EVP/GC open-market sale of 599 shares under a pre-arranged 10b5-1 plan, per SEC Form 4.
Likely minimal near-term impact; any effect would be small and short-lived unless follow-on selling accelerates.
Form 4 insider sales are typically routine when executed under a pre-arranged 10b5-1 plan, and the filing provides no new company-specific performance information.
Market effects
No direct sector read-through; single-company insider transaction.
None indicated.
None indicated.
Counterpoint
Even with a 10b5-1 plan, repeated insider selling can coincide with private concerns; monitor for clustering of sales.
Key entities
- issuerProgyny, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderSwartz Allison
EVP, GC who sold 599 shares on 2026-06-04 under a 10b5-1 plan.
